Inhibrx Biosciences Inc's total assets for Q3 2024 were $222.56M, a decrease of -13.88% from the previous quarter. INBX total liabilities were $44.09M for the fiscal quarter, a 12.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.